TY - CHAP A1 - Daniel Yacoub A2 - Ghada S. Hassan A3 - Nada Alaadine A4 - Yahye Merhi A5 - Walid Mourad ED1 - Efrain Gaxiola Y1 - 2012-04-20 PY - 2012 T1 - CD40 Ligand and Its Receptors in Atherothrombosis N2 - Atherothrombosis has reached pandemic proportions worldwide. It is the underlying condition that results in events leading to myocardial infarction, ischemic stroke and vascular death. As such, it is the leading cause of death worldwide manifested mainly as cardiovascular/cerebrovascular death. The complex and intimate relationship between atherothrombosis and traditional and novel risk factors is discussed in the following chapters of Traditional and Novel Risk Factors in Atherothrombosis - from basic science to clinical and therapeutic concerns. Beginning with pathology and pathophysiology of atherothrombosis, plaque rupture/disruption, this book continues with molecular, biochemical, inflammatory, cellular aspects and finally analyzes several aspects of clinical pharmacology. BT - Traditional and Novel Risk Factors in Atherothrombosis SP - Ch. 5 UR - https://doi.org/10.5772/33289 DO - 10.5772/33289 SN - PB - IntechOpen CY - Rijeka Y2 - 2021-10-17 ER -